The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Nov 2011
Multicenter Study Controlled Clinical TrialTherapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified vaccinia virus Ankara) that codes for MUC1 tumour-associated antigen and interleukin 2. This study assessed TG4010 in combination with first-line chemotherapy in advanced NSCLC. ⋯ Transgene SA, Advanced Diagnostics for New Therapeutic Approaches (ADNA)/OSEO.